Skip to main content
logo
Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.07
+0.06 (0.86%)
At close: Jul 24, 2026, 4:00 PM EDT
7.02
-0.05 (-0.71%)
After-hours: Jul 24, 2026, 7:41 PM EDT

Sagimet Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---2--
Revenue Growth
------
Gross Profit
---2--
Operating Income
-48.74-56.89-54.45-30.74-31.06-23.72
Net Income
-43.51-51.04-45.57-27.88-30.5-24.44
Earnings Per Share
-1.34-1.58-1.45-2.66-165.20-199.40
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
104.54113.12151.2594.932.3556.73
Total Debt
0.040.080.080.070.210.35
Net Cash (Debt)
104.5113.05151.1794.8332.1356.38
Net Cash Growth
-27.70%-25.22%59.41%195.11%-43.01%-28.05%
Net Cash Per Share
3.223.494.829.07174.06305.40

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-39.73-45.65-42.44-23.77-24.49-21.71
Free Cash Flow
-39.73-45.65-42.44-23.77-24.49-21.71
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%--
Operating Margin
----1537.00%--
Pretax Margin
----1393.80%--
Profit Margin
----1393.80%--
FCF Margin
----1188.30%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---62.05--